JP MORGAN/CALL/BOSTON SCIENTIFIC/75/0.1/16.01.26 | Real-time Bid/Ask 03:35:58 2024-06-11 am EDT | ||
| 1.77 EUR / 1.87 EUR | +4.60% |
|
| Current month | +8.07% | ||
| 1 month | +9.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-11 | 1.77 | +1.72% |
| 24-06-10 | 1.74 | +5.45% |
| 24-06-07 | 1.65 | 0.00% |
| 24-06-06 | 1.65 | 0.00% |
| 24-06-05 | 1.65 | +1.85% |
Delayed Quote Börse Stuttgart
Last update June 11, 2024 at 03:22 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK7JZ8 |
| ISIN | DE000JK7JZ81 |
| Date issued | 2024-04-04 |
| Strike | 75 $ |
| Maturity | 2026-01-16 (585 Days) |
| Parity | 10 : 1 |
| Emission price | 0.75 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.77 € |
|---|---|
| Lowest since issue | 1.2 € |
| Spread | 0.1 € |
| Spread % | 5.35% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77.42
USD
Average target price
82.06
USD
Spread / Average Target
+6.00%
- Stock Market
- Warrants
- Warrant
